{"url_path":"/sec/pasg/8-k/2026-06-24/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-24","source_url":"https://www.sec.gov/Archives/edgar/data/1787297/0001104659-26-077306-index.html","accession_number":"0001104659-26-077306","cik":"0001787297","ticker":"PASG","issuer_name":"Passage BIO, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1787297/0001104659-26-077306-index.html","primary_entity_key":"0001787297","primary_entity_name":"Passage BIO, Inc."},"word_count":180,"has_tables":true,"body_markdown":"**Item 7.01. Regulation FD Disclosure.**\n\n \n\n**Press Release**\n\n \n\nOn June 24, 2026, Passage Bio and Remix issued\na joint press release announcing the execution of the Merger Agreement. The press release is furnished as Exhibit 99.1 to this Current\nReport on Form 8-K and incorporated herein by reference, except that the information contained on the websites referenced in the\npress release is not incorporated herein by reference.\n\n \n\n**Investor Presentation**\n\n \n\nOn June 24, 2026, representatives of Passage\nBio and Remix will hold a conference call to investors, which will include an investor presentation. The investor presentation is furnished\nas Exhibit 99.2 to this Current Report on Form 8-K and incorporated herein by reference.\n\n \n\nThe information contained in this Item 7.01, including\nExhibits 99.1 and 99.2, is deemed to have been furnished and shall not be deemed to be “filed” for purposes of Section 18\nof the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section,\nand is not incorporated by reference into any filing under the Securities Act or the Exchange Act."}